Trial Profile
Clinical Trials Insight: 700044737
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 May 2009
Price :
$35
*
At a glance
- Drugs PSN 821 (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors OSI Pharmaceuticals
- 20 May 2009 New trial record.